| Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ... Diabetes care 42 (8), 1593-1603, 2019 | 3518 | 2019 |
| International consensus on use of continuous glucose monitoring T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ... Diabetes care 40 (12), 1631-1640, 2017 | 2106 | 2017 |
| Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines K Kisand, AS Bøe Wolff, KT Podkrajšek, L Tserel, M Link, KV Kisand, ... Journal of Experimental Medicine 207 (2), 299-308, 2010 | 749 | 2010 |
| Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring D Deiss, J Bolinder, JP Riveline, T Battelino, E Bosi, N Tubiana-Rufi, ... Diabetes care 29 (12), 2730-2732, 2006 | 728 | 2006 |
| Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes T Battelino, M Phillip, N Bratina, R Nimri, P Oskarsson, J Bolinder Diabetes care 34 (4), 795-800, 2011 | 651 | 2011 |
| The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial T Battelino, I Conget, B Olsen, I Schütz-Fuhrmann, E Hommel, R Hoogma, ... Diabetologia 55, 3155-3162, 2012 | 607 | 2012 |
| Nocturnal glucose control with an artificial pancreas at a diabetes camp M Phillip, T Battelino, E Atlas, O Kordonouri, N Bratina, S Miller, T Biester, ... New England Journal of Medicine 368 (9), 824-833, 2013 | 487 | 2013 |
| GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus J Ludvigsson, D Krisky, R Casas, T Battelino, L Castaño, J Greening, ... New England Journal of Medicine 366 (5), 433-442, 2012 | 409 | 2012 |
| Continuous glucose monitoring and metrics for clinical trials: an international consensus statement T Battelino, CM Alexander, SA Amiel, G Arreaza-Rubin, RW Beck, ... The lancet Diabetes & endocrinology 11 (1), 42-57, 2023 | 387 | 2023 |
| Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine … M Phillip, T Battelino, H Rodriguez, T Danne, F Kaufman, ... Diabetes care 30 (6), 1653-1662, 2007 | 386 | 2007 |
| International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium–glucose cotransporter (SGLT) inhibitors T Danne, S Garg, AL Peters, JB Buse, C Mathieu, JH Pettus, ... Diabetes care 42 (6), 1147-1154, 2019 | 330 | 2019 |
| A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial RM Bergenstal, R Nimri, RW Beck, A Criego, L Laffel, D Schatz, ... The Lancet 397 (10270), 208-219, 2021 | 317 | 2021 |
| Mixed-meal tolerance test versus glucagon stimulation test for the assessment of β-cell function in therapeutic trials in type 1 diabetes CJ Greenbaum, T Mandrup-Poulsen, PF McGee, T Battelino, B Haastert, ... Diabetes care 31 (10), 1966-1971, 2008 | 313 | 2008 |
| ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes. T Danne, M Phillip, BA Buckingham, P Jarosz‐Chobot, B Saboo, ... Pediatric diabetes 19, 2018 | 289 | 2018 |
| AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies S Meyer, M Woodward, C Hertel, P Vlaicu, Y Haque, J Kärner, A Macagno, ... Cell 166 (3), 582-595, 2016 | 288 | 2016 |
| Diabetes technology—continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline AL Peters, AJ Ahmann, T Battelino, A Evert, IB Hirsch, MH Murad, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 3922-3937, 2016 | 280 | 2016 |
| Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1 P Bastard, E Orlova, L Sozaeva, R Lévy, A James, MM Schmitt, S Ochoa, ... Journal of Experimental Medicine 218 (7), e20210554, 2021 | 272 | 2021 |
| Consensus recommendations for the use of automated insulin delivery technologies in clinical practice M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ... Endocrine reviews 44 (2), 254-280, 2023 | 266 | 2023 |
| ISPAD clinical practice consensus guidelines 2018: diabetes technologies JL Sherr, M Tauschmann, T Battelino, M de Bock, G Forlenza, R Roman, ... Pediatr Diabetes 19 (Suppl 27), 302-325, 2018 | 262 | 2018 |
| Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European … O Moser, MC Riddell, ML Eckstein, P Adolfsson, R Rabasa-Lhoret, ... Diabetologia 63 (12), 2501-2520, 2020 | 248 | 2020 |
Moshe PhillipprofessorE-mail megerősítve itt: tauex.tau.ac.il
